Related Experiment Video
Updated: May 4, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Methodological issues of retrospective studies assessing health outcomes of potential clopidogrel-statin interaction
1Division of Pharmacy Practice and Administration, The University of Missouri, Kansas City, MO, USA.
Insights
Investigating clopidogrel-statin interactions reveals methodological flaws in retrospective studies. Addressing these limitations is crucial for accurately assessing the clinical impact of these commonly coprescribed medications.
Area of Science:
- Pharmacology
- Clinical Research Methodology
Background:
- Clopidogrel and statins are frequently prescribed together for atherosclerotic diseases.
- Initial concerns about clopidogrel-statin interactions from ex vivo studies lack robust support from health outcome studies.
Purpose of the Study:
- To critically evaluate the methodological issues in studies examining clopidogrel-statin drug interactions.
- To focus on the limitations of retrospective studies assessing health outcomes related to this drug combination.
Main Methods:
- A comprehensive literature search was performed for articles on clopidogrel-statin interactions published in English from January 2003 onwards.
Main Results:
- Retrospective studies often suffer from a lack of central blinded adjudication of clinical events.
- Incomplete confounder assessment, inadequate comparison groups, and inconsistent medication dosage are significant limitations.
Conclusions:
- Methodological improvements are necessary for retrospective studies to accurately evaluate clopidogrel-statin interactions.
- Well-designed retrospective research is essential for understanding the clinical impacts of this drug combination.
Objective:
Clopidogrel and statins have been commonly coprescribed to patients with atherosclerotic diseases. Clopidogrel-statin interaction was initially described by ex vivo studies, but was not well supported by studies examining health outcomes. This personal view article aims to discuss methodological issues of these studies, especially the retrospective studies assessing health outcomes.
Methods:
A comprehensive literature search was conducted to identify journal articles of clopidogrel-statin interaction that were published in English since January 2003.
Key Findings:
The limitations of retrospective studies include lack of central blinded adjudication of clinical events, incomplete assessment of confounders, inadequate comparison groups and inconsistent use of medication dosage.
Conclusion:
A well-designed retrospective study may better understand potential clopidogrel-statin interaction and its clinical impacts.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...